TECH

BIO-TECHNE CORP

Healthcare | Large Cap

$0.36

EPS Forecast

$290.4

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon
REPLReplimune Group IncBLUEBluebird Bio IncCRSPCrispr Therapeutics AgDNLIDenali Therapeutics IncHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncNBIXNeurocrine Biosciences IncNVAXNovavax IncRGENRepligen CorpMRNAModerna Inc